These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 4542262)

  • 1. Antibody-dependent lymphocyte-mediated cytotoxicity in man: no requirement for lymphocytes with membrane-bound immunoglobulin.
    Wisloff F; Froland SS
    Scand J Immunol; 1973; 2(2):151-7. PubMed ID: 4542262
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody-dependent cytotoxicity mediated by human Fc-receptor-bearing cells lacking markers for B- and T-lymphocytes.
    Wisloff F; Froland SS; Michaelsen TE
    Int Arch Allergy Appl Immunol; 1974; 47(1):139-54. PubMed ID: 4603056
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibody-dependent cell-mediated cytotoxicity due to a "null" lymphoid cell.
    Greenberg AH; Hudson L; Shen L; Roitt IM
    Nat New Biol; 1973 Mar; 242(117):111-3. PubMed ID: 4541031
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis, transport, dynamics and fate of cell surface Ig and alloantigens in murine lymphocytes.
    Vitetta ES; Uhr JW
    Transplant Rev; 1973; 14():50-75. PubMed ID: 4542308
    [No Abstract]   [Full Text] [Related]  

  • 5. Lymphocyte-mediated cytotoxicity induced by humoral antibodies. Mechanism of induction and surface markers of the effector cells.
    Perlmann P; Perlmann H; Müller-Eberhard HJ
    Int Arch Allergy Appl Immunol; 1973; 45(1):278-80. PubMed ID: 4542233
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibody-dependent cell-mediated cytotoxicity. II. Early interactions between effector and target cells.
    Scornik JC
    J Immunol; 1974 Nov; 113(5):1519-26. PubMed ID: 4418199
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibody-mediated target cell lysis by non-immune cells. Characterization of the antibody and effector cell populations.
    Gelfand EW; Resch K; Prester M
    Eur J Immunol; 1972 Oct; 2(5):419-24. PubMed ID: 5084393
    [No Abstract]   [Full Text] [Related]  

  • 8. Allograft immunity in vitro. VI. Autonomy of T lymphocytes in target cell destruction.
    Andersson LC; Nordling S; Häyry P
    Scand J Immunol; 1973; 2(2):107-13. PubMed ID: 4269569
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on the cytotoxic activity of human lymphoid cells activated by concanavalin A.
    Wislöff F; Fröland SS
    Int Arch Allergy Appl Immunol; 1973; 45(3):456-66. PubMed ID: 4542732
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro cytotoxicity of human lymphocytes: reduction of the lymphocyte cytotoxicity induced by antibodies or phytohemagglutinin by removing immune-complex-binding cells.
    Hallberg T
    Scand J Immunol; 1974; 3(5):645-54. PubMed ID: 4138557
    [No Abstract]   [Full Text] [Related]  

  • 11. Membrane-bound immunoglobulin (Ig) and in vitro production of Ig by lymphoid cells from patients with primary immunodeficiencies.
    Aiuti F; Fontana L; Gatti RA
    Scand J Immunol; 1973; 2(1):9-16. PubMed ID: 4580485
    [No Abstract]   [Full Text] [Related]  

  • 12. Cell-mediated immune reactions in vitro: cytotoxicity of lymphocytes activated by phytohemagglutinin and anti-immunoglobulin serum.
    Resch K; Fischer H
    Eur J Immunol; 1971 Aug; 1(4):271-5. PubMed ID: 5316633
    [No Abstract]   [Full Text] [Related]  

  • 13. Redistribution and fate of Ig complexes on surface of B lymphocytes: functional implications and mechanisms.
    Unanue ER; Karnovsky MJ
    Transplant Rev; 1973; 14():184-210. PubMed ID: 4580724
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunoglobulin and theta-bearing murine leukemias and lymphomas.
    Shevach EM; Stobo JD; Green I
    J Immunol; 1972 May; 108(5):1146-51. PubMed ID: 4112916
    [No Abstract]   [Full Text] [Related]  

  • 15. Lymphocyte subpopulations in chronic lymphocytic leukemia. Characterization by cell surface markers, cytotoxic activity, and mitogenic stimulation.
    Mellstedt H; Pettersson D
    Scand J Immunol; 1974; 3(3):303-10. PubMed ID: 4546857
    [No Abstract]   [Full Text] [Related]  

  • 16. An acute-leukemia antigen: correlation with clinical status.
    Halterman RH; Leventhal BG; Mann DL
    N Engl J Med; 1972 Dec; 287(25):1272-4. PubMed ID: 4508573
    [No Abstract]   [Full Text] [Related]  

  • 17. Surface-bound immunoglobulin on lymphocytes from normal and immunodeficient humans.
    Froland SS; Natvig JB
    Scand J Immunol; 1972; 1(1):1-12. PubMed ID: 4561501
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytotoxicity mediated by human lymphocyte-dependent antibody in a rapid assay with adherent target cells.
    Yust I; Wunderlich JR; Mann DL; Buell DN
    J Immunol; 1973 Jun; 110(6):1672-81. PubMed ID: 4712926
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of 2-mercaptoethanol (2-ME) treatment of IgG antibody on its ability to induce cytotoxicity in nonsensitized lymphocytes.
    Denk H; Stemberger H; Wiedermann G; Eckerstorfer R; Tappeiner G
    Cell Immunol; 1974 Sep; 13(3):489-92. PubMed ID: 4141652
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibody-dependent cell-mediated cytotoxicity in the mouse. I. Surface characteristics of an effecter cell.
    Pross HF; Tracey DE; Wigzell H; Schirrmacher V
    Scand J Immunol; 1974; 3(6):769-80. PubMed ID: 4218362
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.